Literature DB >> 6332220

Experimental Pneumocystis carinii infection in nude rats.

T Furuta, K Ueda, K Fujiwara.   

Abstract

The role of cell-mediated and humoral immunities to Pneumocystis carinii infection was studied on athymic nude rats and their heterozygous euthymic littermates inoculated intranasally with 10(6) cysts. Some of both groups were injected subcutaneously with cortisone (25 mg) twice a week. At 30 and 60 days postinoculation a large number of cysts were detected in the lung of cortisone treated euthymic rats as well as athymic rats with or without cortisone treatment. IgG antibody appeared in all groups of rats at 60 days post-inoculation while IgM antibody was not detectable. Delayed type footpad reaction to P. carinii antigen was recognized in euthymic rats without cortisone at 4 and 5 weeks postinfection but not in those rats with cortisone or without infection. These results suggest that cell-mediated immunity is important for protection of P. carinii infection in rat.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6332220

Source DB:  PubMed          Journal:  Jpn J Exp Med        ISSN: 0021-5031


  10 in total

1.  Superiority of methylprednisolone over dexamethasone for induction of Pneumocystis carinii infection in rats.

Authors:  A Sukura; T Soveri; L A Lindberg
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

2.  Severe pulmonary pneumocystosis in simian acquired immunodeficiency syndrome induced by simian immunodeficiency virus: its characterization by the polymerase-chain-reaction method and failure of experimental transmission to immunodeficient animals.

Authors:  T Furuta; M Fujita; R Mukai; I Sakakibara; T Sata; K Miki; M Hayami; S Kojima; Y Yoshikawa
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

3.  Spontaneous Pneumocystis carinii pneumonia in immunodeficient mutant scid mice. Natural history and pathobiology.

Authors:  J B Roths; J D Marshall; R D Allen; G A Carlson; C L Sidman
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

4.  Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+ but not CD8+ T cells into severe combined immunodeficiency mice.

Authors:  J B Roths; C L Sidman
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

5.  Single and combined humoral and cell-mediated immunotherapy of Pneumocystis carinii pneumonia in immunodeficient scid mice.

Authors:  J B Roths; C L Sidman
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

6.  Serological observations of Pneumocystis carinii infection in humans.

Authors:  K Tanabe; T Furuta; K Ueda; H Tanaka; K Shimada
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

7.  Cellular and humoral immune responses of mice subclinically infected with Pneumocystis carinii.

Authors:  T Furuta; K Ueda; K Fujiwara; K Yamanouchi
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

8.  Specific T-cell response to a Pneumocystis carinii surface glycoprotein (gp120) after immunization and natural infection.

Authors:  D J Fisher; F Gigliotti; M Zauderer; A G Harmsen
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

9.  Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models.

Authors:  F Gigliotti; W T Hughes
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

10.  Outbreaks of Pneumocystis carinii pneumonia in colonies of immunodeficient mice.

Authors:  P D Walzer; C K Kim; M J Linke; C L Pogue; M J Huerkamp; C E Chrisp; A V Lerro; S K Wixson; E Hall; L D Shultz
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.